Download the POV: https://ow.ly/su8V50SAC3l Do you feel like your brand plan involves all relevant functions or that your external partners are collaborating effectively to help the brand plan? One third of brand planning executives that we surveyed across biopharmaceuticals, diagnostics and medical devices, did not. Download the POV to learn more survey insights and ways to fuel your brand plan with data-driven strategies and seamless integration of global contexts, cross-functional inputs and market analysis. #pharmamarketing #AI #brandplanning #generativeAI #pharma #survey
EVERSANA INTOUCH’s Post
More Relevant Posts
-
Artificial Intelligence (AI) Transforming Healthcare and Pharmaceuticals! 🌟 Discover how AI is revolutionizing drug discovery, patient care, and diagnostics, promising more efficient, accurate, and personalized healthcare solutions. From accelerating drug discovery to enhancing diagnostic accuracy and personalizing treatment plans, the future of healthcare is here! 🚀💊🩺 #AI #Healthcare #Pharmaceuticals #Innovation #FutureOfMedicine #RVGroup #RVOPV
To view or add a comment, sign in
-
-
Does your organization know what changes to expect for the future of outsourced medical imaging? We have you covered: our latest research focusing on this space offers insight into what sponsors are looking for in a medical imaging provider, as well as how respondents view the providers they've worked with and how they approach the outsourcing process. These data are beneficial for imaging providers, study sponsors, CROs, and investors as they seek to better understand the market and buying process for medical imaging services: https://lnkd.in/dEkvH9q8 #pharmaceuticals #medicalimaging #clinicaltrials #marketresearch Biospective Inc. CALYX Canfield Scientific Cardialysis Clario ICON plc Imaging Endpoints Invicro IXICO Median Technologies Medical Metrics, Inc. Medpace Philips Pharma Solutions, formerly BioTel Research Radiantsage Resonance Health Ltd WCG WorldCare Clinical (now Voiant)
To view or add a comment, sign in
-
-
𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐀𝐈 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐚𝐧𝐝 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 In the dynamic field of healthcare, Generative AI stands out as a game-changer. From accelerating drug discovery to providing personalized medical solutions, the impact of AI is profound. Join the discussion on how these innovations are shaping the future of healthcare. #HealthcareInnovation, #AIInHealthcare, #Pharmaceuticals, #PersonalizedHealthcare, #TechInMedicine
To view or add a comment, sign in
-
-
>NEXT Survey Invite - The GenAI for commercial and medical teams 🔥> We want your insights! Participate here - https://lnkd.in/dn8fajWc Your insights are invaluable as we delve into: ▪️ The evolving roles of AI in pharma ▪️ Enhancing customer engagement and communication ▪️ Overcoming challenges and fostering team collaboration This survey is powered by Exeevo. Thank you for being a part of this initiative! #pharma #pharmaceuticals #tech #research #commercial #commercialstrategy #digitaltransformation #digital #ai #medical
To view or add a comment, sign in
-
-
Explore our latest healthcare, pharma & life sciences newsletter for an in-depth overview of the new digital era for life sciences. https://bit.ly/3StwNzz #zeposyannopoulos #zeyanewsletters
To say today is an era of opportunity but also risk for the Life Sciences companies might be an understatement. Pharmaceutical, medical device, biotech and other companies of the Life Sciences sector are all identifying the continued technological advancement as a top opportunity to use technology to solve complex health challenges. Life Sciences companies are increasingly turning to AI and other digital tools in an attempt to accelerate and improve traditional processes towards a more efficient system, extending from the identification of new products to the design of clinical trials, management of supply chains and provision of remote services to the patients. Explore our latest healthcare, pharma & life sciences newsletter for an in-depth overview of the new digital era for life sciences. https://bit.ly/3StwNzz #zeposyannopoulos #zeyanewsletters
To view or add a comment, sign in
-
-
Pharmaceutical companies are increasingly moving beyond the "physician-as-customer" model to engage patients directly. However, there remains a significant disconnect in patient information, with only about half of providers providing patients as much information as desired (despite being rated as a highly trusted information source). In our latest blog, authored by Mariah Hanley, learn how we're leveraging generative AI to analyze competitor patient engagement strategies and identify market opportunities. https://lnkd.in/dXKYG3mg #AI #PatientEngagement #Pharma #Healthcare #Innovation #GenerativeAI
To view or add a comment, sign in
-
-
Clinging to outdated models is a surefire way to fall behind in the #pharmaceutical industry's rapidly evolving landscape. Staying updated with industry trends in #AI and #DigitalTherapeutics has never been more important and those who don't act quickly will quickly fall behind. Enjoy this great insight from Dr. Andrée Bates ➡️ https://lnkd.in/gsSPDwqc Reach out if you'd like to chat about how #ProcessX can help you optimize operations, enhance your decision-making processes, and provide better patient care. #USDM #LifeSciences
To view or add a comment, sign in
-
We support both Marketing + Medical Affairs pharma stakeholders in 30+ countries: reprints and eprints, professional medical writing, creative medcomms, medical education
🔬 Exciting News in Medical Literature! 🔍 The New England Journal of Medicine NEJM Group is leading the way with a dedicated focus on Artificial Intelligence 🤖. In their latest editorial, they express optimism about the vast potential AI holds for healthcare professionals and patients. . ⏳👏📚 The Link to the article here: Injecting Artificial Intelligence into Medicine https://lnkd.in/dtAbMMct #redactionmedicale, #medicalwriting, #reprints, #medecine, #medicalinformation, #pharmaceutical, #biotechnology, #marketing #pharmaceuticalindustry, #NEJM, #industriepharmaceutique, #affairesmedicales, #intelligenceartificielle
To view or add a comment, sign in
-
-
📢 Today's the Day! Join the insightful keynote on "𝙄𝙨 𝘼𝙄 𝙋𝙝𝙖𝙧𝙢𝙖’𝙨 𝙜𝙤𝙡𝙙𝙚𝙣 𝙥𝙞𝙡𝙡?" at HLTH Europe! Explore how AI is reshaping pharmaceuticals from drug discovery to patient care with Bayer’s Chief Medical Officer, Mike Devoy MD, and other industry leaders ✨. 🕒 When: 𝐓𝐎𝐃𝐀𝐘, 2:20 𝐏𝐌 - 2:40 𝐏𝐌 📍 Where: Main Stage Don't miss out on insights that could define the future of AI in Pharma! 🚀 #hltheurope #healthcare #digitalhealth #healthtech
To view or add a comment, sign in
-
-
As pharmaceutical marketers, we aim to bridge the gap between cutting-edge research and patient care. By 2025, AI in healthcare is projected to grow by 41.5% annually, enhancing drug discovery and personalized treatment. Big data analytics can increase R&D efficiency by up to 40%, while precision medicine, expected to grow by 11.23% annually, ensures targeted, effective therapies. These strategies enhance patient outcomes and engagement. How are you ensuring your strategies align with this mission? Share your thoughts below! 💬 #PharmaLeadership #PatientCentricity #MarketingStrategies #HealthcareMarketing #WednesdayThoughts #healthcare #strategies #neomarketer
To view or add a comment, sign in
-